SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 224 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,330,000 | -8.4% | 157,066 | -0.1% | 0.63% | -2.6% |
| Q2 2023 | $4,726,000 | -17.5% | 157,216 | -0.6% | 0.65% | -21.2% |
| Q1 2023 | $5,728,000 | -8.2% | 158,094 | -9.6% | 0.82% | -8.7% |
| Q4 2022 | $6,240,000 | +39.0% | 174,946 | +31.9% | 0.90% | +29.4% |
| Q3 2022 | $4,488,000 | +46.2% | 132,598 | +25.0% | 0.70% | +51.1% |
| Q2 2022 | $3,069,000 | – | 106,105 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
| Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
| CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
| FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
| Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
| KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
| SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
| Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
| Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |